StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Stage applied for a PRS seven days ago

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Nov 09, 2021 1:03pm

96 Views

Post# 34105510

RE:RE:Stage applied for a PRS seven days ago

This would make the most sence seeing the track record.

Colonsentry = no money made

Come out with new better product Aristotle for cancer = no money made

I know lets say we are testing for a whole bunch of other things now that will make chances to our $$$

Its a sign when none of your products make money you keep "improving them"

Gotta justify the next PP somehow

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property